PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Shareholding Pattern

Beta Drugs Limited

Promoter holding in Beta Drugs Limited was 58.91% in Sep 2026, down 0.19 points from the previous quarter. Since Dec 2024 it has fallen 7.82 points.

By quarter

Promoters58.91%
Public41.09%
Promoter shares pledged (latest): 0.00% of promoter holding

Quarter by quarter

QuarterPromotersPublic
Sep '26 58.91%▼0.19 41.09%▲0.19
Jun '26 59.10%=0.00 40.90%=0.00
Mar '26 59.10%▼5.80 40.90%▲5.80
Dec '25 64.90%▼1.83 35.10%▲1.83
Sep '25 66.73%=0.00 33.27%=0.00
Jun '25 66.73%=0.00 33.27%=0.00
Mar '25 66.73%=0.00 33.27%=0.00
Dec '24 66.73%=0.00 33.27%=0.00

Trend

Compared with similar companies

Promoter holding in Beta Drugs Limited is higher than 57% of companies in the Healthcare sector in India.

Similar-sized companies in the same sector, latest quarter on record.

Questions

What is Beta Drugs Limited's promoter holding?

Promoters held 58.91% of Beta Drugs Limited as of 30 Sep 2026, and the public held 41.09%.

Has Beta Drugs Limited's promoter holding increased?

No, it fell by 0.19 percentage points in the quarter to Sep 2026.

Are any promoter shares of Beta Drugs Limited pledged?

No promoter shares are recorded as pledged.

How has Beta Drugs Limited's promoter holding changed over the years?

Over a longer period, promoter holding went from 66.68% in Sep 2021 to 58.91% in Sep 2026, down 7.77 points.

How does Beta Drugs Limited's promoter holding compare with similar companies?

Promoter holding in Beta Drugs Limited is higher than 57% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.

From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.